Merimepodib (MMPD) in Triple Combination for the Treatment of Chronic Hepatitis C

PHASE2CompletedINTERVENTIONAL
Enrollment

315

Participants

Timeline

Start Date

July 31, 2004

Study Completion Date

October 31, 2006

Conditions
Hepatitis CHepatitis
Interventions
DRUG

Merimepodib

DRUG

PEG-Interferon-alpha 2a (Pegasys®)

DRUG

Ribavirin (Copegus®)

Trial Locations (67)

10021

Ira M. Jacobson, M.D., New York

10029

Douglas T. Dieterich, M.D., New York

11030

David Eric Bernstein, M.D., Manhasset

15224

Peter J. Molloy, M.D., Pittsburgh

17033

Jill P. Smith, M.D., Hershey

19141

Victor Araya, M.D., Philadelphia

20901

Milton J. Koch, M.D., Silver Spring

21229

Natarajan Ravendhran, M.D., Baltimore

21287

Mark Sulkowski, M.D., Baltimore

21401

Michael Epstein, M.D., Annapolis

22911

Daniel Pambianco, M.D., Charlottesville

23249

Mitchell Shiffman, M.D., Richmond

27710

Andrew Muir, M.D., Durham

28207

Robert Reindollar, M.D., Charlotte

28304

John E. Poulous, M.D., Fayetteville

29203

James Scott Strohecker, M.D., Columbia

30060

Arnold L. Lentnek, M.D., Marietta

33136

Eugene R. Schiff, M.D., Miami

34684

Jawahar L. Taunk, M.D., Palm Harbor

35209

Joseph L. Cochran, M.D., Birmingham

35801

Suresh Karne, M.D., Ph.D., Huntsville

37205

Ronald Pruitt, M.D., Nashville

38120

Lawrence D. Wruble, M.D., Memphis

40536

Alvaro G. Koch, M.D., Lexington

45219

Mark E. Jonas, M.D., Cincinnati

48202

Stuart C. Gordon, M.D., Detroit

55446

Jeffrey Rank, M.D., Saint Paul

60452

Gerald J. Mingoletti, M.D., Oak Forest

60611

Steven L. Flamm, M.D., Chicago

60637

Helen Te, M.D., Chicago

62703

Donald R. Graham, M.D., Springfield

63104

Adrian Di Bisceglie, M.D., St Louis

70115

Luis A. Balart, M.D., New Orleans

70121

Robert Perrillo, M.D., New Orleans

70808

Shaban Faruqui, M.D., Baton Rouge

70809

Robert M. Be, M.D., Baton Rouge

71201

Bal Raj Bhandari, M.D., Monroe

74104

Harvey A. Tatum, M.D., Tulsa

75246

Gary L. Davis, M.D., Dallas

77004

George G. Burnazian, M.D., Houston

77030

Rise Stribling, M.D., Houston

78215

Eric J. Lawitz, M.D., San Antonio

80113

Marcelo Kugelmas, M.D., Englewood

83702

Ellen B. Hunter, M.D., Boise

85054

Vijayan Balan, M.D., Phoenix

91105

Myron J. Tong, M.D., Ph.D., Pasadena

92123

Michael T. Bennett, M.D., San Diego

92154

Lisa M. Nyberg, M.D., San Diego

92801

Michael P. DeMicco, M.D., Anaheim

93703

Prahalad B. Jajodia, M.D., Fresno

94115

Natalie Bzowej, M.D., San Francisco

94304

Ramsey Cheung, M.D., Palo Alto

97225

George Koval, M.D., Portland

98195

Robert L. Carithers, M.D., Seattle

98405

David Winters McEniry, M.D., Tacoma

Michael F. Lyons II, M.D., Tacoma

90095-7054

F. Fred Poordad, M.D., Los Angeles

06030

Herbert L. Bonkovsky, M.D., Farmington

02703

David N. Schwartz, M.D., Attleboro

02215

Nezam Afdhal, M.D., Boston

01655

Lawton Shick, M.D., Worcester

55905-0002

John B. Gross, M.D., Rochester

07932

William C. Sloan, Florham Park

08618

Rajendra Prasad Gupta, M.D., Trenton

75390-9016

William M. Lee, M.D., Dallas

22031-5216

Vinod Rustgi, M.D., Fairfax

98004-3049

Robert A. Wohlman, M.D., Bellevue

All Listed Sponsors
lead

Vertex Pharmaceuticals Incorporated

INDUSTRY

NCT00088504 - Merimepodib (MMPD) in Triple Combination for the Treatment of Chronic Hepatitis C | Biotech Hunter | Biotech Hunter